Department of Neurosurgery, University of Florida, Gainesville, Florida 32610, USA.
Neurosurgery. 2011 Apr;68(4):974-84; discussion 984. doi: 10.1227/NEU.0b013e318208f3a1.
Nonvestibular schwannomas are uncommon tumors of the brain often treated by surgical resection. Surgery may be associated with high morbidity.
We present a series of nonvestibular schwannomas treated with linear accelerator radiosurgery during a 19-year period.
This is a retrospective analysis of patients who underwent treatment of nonvestibular schwannomas at the University of Florida with linear accelerator radiosurgery between August 1989 and February 2008. Forty-nine patients underwent treatment during the study period, and 6 were lost to follow up. The mean age was 51 years (range, 17-82 years), 39% had previous surgical resection, and 67% presented with preradiosurgery cranial nerve deficits. There were 25 trigeminal, 18 jugular foramen, 2 facial, 2 oculomotor, 1 hypoglossal, and 1 high cervical schwannomas. The median tumor volume was 5.3 mL (range, 0.3-24.5 mL), treated with a median dose of 1250 cGy (range, 1000-1500 cGy). Study endpoints were actuarial local tumor control and neurological outcome.
Forty-three patients were available for a median follow-up of 37 months (range, 6-210 months). Actuarial local tumor control was 97% at 1 year, 91% at 4.5 years, and 83% at 5 years. There were 4 new cranial nerve deficits (9%) including facial numbness (2 patients), anesthesia dolorosa (1 patient), and facial weakness (1 patient). Thirty-nine percent had documented clinical and/or symptomatic improvement. There were no other morbidity and no mortality with treatment.
Radiosurgery for nonvestibular schwannomas offers good actuarial local tumor control and has superior morbidity compared with surgical resection. This is the largest linear accelerator radiosurgical series, and the second largest radiosurgical series reported to date.
非前庭神经鞘瘤是一种不常见的脑部肿瘤,常通过手术切除进行治疗。手术可能会导致较高的发病率。
我们展示了一组在 19 年期间接受线性加速器放射外科治疗的非前庭神经鞘瘤病例。
这是一项回顾性分析,研究对象为 1989 年 8 月至 2008 年 2 月期间在佛罗里达大学接受线性加速器放射外科治疗的非前庭神经鞘瘤患者。在研究期间,有 49 名患者接受了治疗,其中 6 名患者失访。患者的平均年龄为 51 岁(范围,17-82 岁),39%有过手术切除史,67%在放射外科治疗前存在颅神经功能障碍。肿瘤类型包括 25 例三叉神经鞘瘤、18 例颈静脉孔神经鞘瘤、2 例面神经鞘瘤、2 例动眼神经鞘瘤、1 例舌下神经鞘瘤和 1 例高位颈神经鞘瘤。肿瘤体积中位数为 5.3ml(范围,0.3-24.5ml),治疗剂量中位数为 1250cGy(范围,1000-1500cGy)。研究终点为肿瘤局部控制的实际生存率和神经学结果。
43 名患者可获得中位随访时间为 37 个月(范围,6-210 个月)。1 年时的肿瘤局部控制实际生存率为 97%,4.5 年时为 91%,5 年时为 83%。有 4 例新出现的颅神经功能障碍(9%),包括面部麻木(2 例)、感觉异常性疼痛(1 例)和面部无力(1 例)。39%的患者出现了有记录的临床和/或症状改善。治疗后无其他并发症和死亡。
对于非前庭神经鞘瘤,放射外科治疗可获得良好的肿瘤局部控制实际生存率,并且与手术切除相比具有更好的发病率。这是最大的一组线性加速器放射外科治疗系列,也是迄今为止第二大放射外科治疗系列。